Cargando…
Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792521/ https://www.ncbi.nlm.nih.gov/pubmed/31407505 http://dx.doi.org/10.1002/cam4.2496 |
_version_ | 1783459174914457600 |
---|---|
author | Tao, Lianyuan Yu, Haibo Dong, Yadong Tian, Guanjing Ren, Zhiyuan Li, Deyu |
author_facet | Tao, Lianyuan Yu, Haibo Dong, Yadong Tian, Guanjing Ren, Zhiyuan Li, Deyu |
author_sort | Tao, Lianyuan |
collection | PubMed |
description | BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from the Surveillance Epidemiology and End Results (SEER) database. The characteristics of type 2 CUP from different sources were analyzed. For each source of type 2 CUP, tumors of the corresponding T(n)N(0‐X)M(1) stage were used as controls. RESULTS: A total of 8505 patients with type 2 CUP were included in this analysis. Type 2 CUP shows an increasing trend, while type 1 shows the opposite. Type 2 CUPs have significant differences with stage IV of the same pathological primary lesion. Many characteristics influenced the prognosis of type 2 CUP patients, including marital status, age, race, sex, registration time, lymph node metastasis, surgery, chemotherapy, and radiation. CONCLUSION: Our study suggests that identifying the source of metastasis is the key to the selection of treatment and the determination of the prognosis for CUP. |
format | Online Article Text |
id | pubmed-6792521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67925212019-10-21 Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study Tao, Lianyuan Yu, Haibo Dong, Yadong Tian, Guanjing Ren, Zhiyuan Li, Deyu Cancer Med Clinical Cancer Research BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from the Surveillance Epidemiology and End Results (SEER) database. The characteristics of type 2 CUP from different sources were analyzed. For each source of type 2 CUP, tumors of the corresponding T(n)N(0‐X)M(1) stage were used as controls. RESULTS: A total of 8505 patients with type 2 CUP were included in this analysis. Type 2 CUP shows an increasing trend, while type 1 shows the opposite. Type 2 CUPs have significant differences with stage IV of the same pathological primary lesion. Many characteristics influenced the prognosis of type 2 CUP patients, including marital status, age, race, sex, registration time, lymph node metastasis, surgery, chemotherapy, and radiation. CONCLUSION: Our study suggests that identifying the source of metastasis is the key to the selection of treatment and the determination of the prognosis for CUP. John Wiley and Sons Inc. 2019-08-13 /pmc/articles/PMC6792521/ /pubmed/31407505 http://dx.doi.org/10.1002/cam4.2496 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Tao, Lianyuan Yu, Haibo Dong, Yadong Tian, Guanjing Ren, Zhiyuan Li, Deyu Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title | Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title_full | Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title_fullStr | Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title_full_unstemmed | Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title_short | Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study |
title_sort | metastases with definitive pathological diagnosis but no detectable primary tumor: a surveillance epidemiology and end results‐based study |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792521/ https://www.ncbi.nlm.nih.gov/pubmed/31407505 http://dx.doi.org/10.1002/cam4.2496 |
work_keys_str_mv | AT taolianyuan metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy AT yuhaibo metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy AT dongyadong metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy AT tianguanjing metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy AT renzhiyuan metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy AT lideyu metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy |